Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrew Burke
Observed name:
A. Burke
Institutions:
The Royal Free Hospital,
University College London
Observed institutions:
LifeArc,
Institut Pasteur,
The Royal Free Hospital,
University of Oxford,
University College London
OpenAlex ID:
A5044880258
The Anti-HIV Activity and Mechanisms of Action of Pure Compounds Isolated fromRosa damascena
1996
·
Naheed Mahmood
, Sonia Piacente
, et al.
·
Biochemical and Biophysical Research Communications
·
230
Inhibition of HIV infection by flavanoids
1993
·
Naheed Mahmood
, Cosimo Pizza
, et al.
·
Antiviral Research
·
109
Synthesis and HIV-1 inhibition of novel benzimidazole derivatives
1995
·
John M. Gardiner
, Colin R. Loyns
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
50
Substantial Correlation between HIV Type 1 Drug-Associated Resistance Mutations in Plasma and Peripheral Blood Mononuclear Cells in Treatment-Experienced Patients
2000
·
Helen L. Devereux
, Clive Loveday
, et al.
·
AIDS Research and Human Retroviruses
·
48
Administration Of Hepatitis A Vaccine To A Military Population By Needle And
1995
·
C. H. Hoke Jr.
, J. E. Egan
, et al.
·
The Journal of Infectious Diseases
·
26
In vivo HIV-1 replicative capacity in early and advanced infection
1999
·
Andrew N. Phillips
, Angela R. McLean
, et al.
·
AIDS
·
25
Reduction in Human Immunodeficiency Virus Type 1 Mutations Associated with Drug Resistance after Initiating New Therapeutic Regimens in Pretreated Patients
2000
·
Helen L. Devereux
, Clive Loveday
, et al.
·
The Journal of Infectious Diseases
·
13
Evaluation of the Antioxidant and Antiviral Actions of Herbal Preparations: Rovital and Carciverin V (C1983)
1996
·
Okezie I. Aruoma
, Barry Halliwell
, et al.
·
Phytotherapy Research
·
4
Differences in the dynamics of viral rebound and evolution of resistance between CBV/NVP and CBV/ABC (NORA sub study of DART trial) uncovered in the absence of viral load monitoring in real time.
2008
·
N. Ndembi
, D Pillay
, et al.
·
3
Prevalence and in vitro characteristics of reverse transcriptase (RT) N348I mutation in non-B subtypes, in the absence of viral load monitoring, in the DART Study (NORA substudy).
2009
·
Adele McCormick
, Andrew Burke
, et al.
·
2
Show more works
View as search
Works count:
10
Citation count:
510
H-index:
7
I10-index:
7
Year
Topic
Type